These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27198504)

  • 1. High frequency of JAK2 exon 12 mutations in Korean patients with polycythaemia vera: novel mutations and clinical significance.
    Park CH; Lee KO; Jang JH; Jung CW; Kim JW; Kim SH; Kim HJ
    J Clin Pathol; 2016 Aug; 69(8):737-41. PubMed ID: 27198504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of low allele burden of JAK2 exon 12 mutations using TA-cloning in patients with erythrocytosis.
    Ohyashiki JH; Hisatomi H; Shimizu S; Sugaya M; Ohyashiki K
    Jpn J Clin Oncol; 2009 Aug; 39(8):509-13. PubMed ID: 19491085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of JAK2 Exon 12 Mutations in JAK2 V617F-Negative Polycythemia Vera Patients by Cloning Technique.
    Leszczynska A; Grzenkowicz-Wydra J; Chmielewska-Gorycka L; Bieniaszewska M; Hellmann A
    Acta Haematol; 2016; 136(2):123-8. PubMed ID: 27410038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis.
    Williams DM; Kim AH; Rogers O; Spivak JL; Moliterno AR
    Exp Hematol; 2007 Nov; 35(11):1641-6. PubMed ID: 17920755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel JAK2 exon 12 mutation identified in the retrospective analysis of paraffin-embedded tissues of polycythemia vera patients.
    Burjanivova T; Marcinek J; Lasabova Z; Minarik G; Szepe P; Balharek T; Vanochova A; Polacek H; Plank L
    Diagn Mol Pathol; 2009 Jun; 18(2):108-11. PubMed ID: 19430293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycythaemia Vera among Sudanese Patients with Special Emphasis on JAK2 Mutations.
    Ibrahim IK; Hassan R; Ali EW; Omer A
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):41-44. PubMed ID: 30677867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.
    Scott LM; Tong W; Levine RL; Scott MA; Beer PA; Stratton MR; Futreal PA; Erber WN; McMullin MF; Harrison CN; Warren AJ; Gilliland DG; Lodish HF; Green AR
    N Engl J Med; 2007 Feb; 356(5):459-68. PubMed ID: 17267906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype.
    Larsen TS; Pallisgaard N; Møller MB; Hasselbalch HC
    Eur J Haematol; 2007 Dec; 79(6):508-15. PubMed ID: 17961178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High percentage of JAK2 exon 12 mutation in Asian patients with polycythemia vera.
    Yeh YM; Chen YL; Cheng HY; Su WC; Chow NH; Chen TY; Ho CL
    Am J Clin Pathol; 2010 Aug; 134(2):266-70. PubMed ID: 20660330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [JAK2 V617F and exon 12 genetic variations in Korean patients with BCR/ABL1-negative myeloproliferative neoplasms].
    Kim JT; Cho YG; Choi SI; Lee YJ; Kim HR; Jang SJ; Moon DS; Park YJ; Park G
    Korean J Lab Med; 2010 Dec; 30(6):567-74. PubMed ID: 21157140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow morphologic features in polycythemia vera with JAK2 exon 12 mutations.
    Lakey MA; Pardanani A; Hoyer JD; Nguyen PL; Lasho TL; Tefferi A; Hanson CA
    Am J Clin Pathol; 2010 Jun; 133(6):942-8. PubMed ID: 20472853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera.
    Pardanani A; Lasho TL; Finke C; Hanson CA; Tefferi A
    Leukemia; 2007 Sep; 21(9):1960-3. PubMed ID: 17597810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JAK2 exon 12 mutations in cases with JAK2V617F-negative polycythemia vera and primary myelofibrosis.
    Maddali M; Kulkarni UP; Ravindra N; Jajodia E; Arunachalam AK; Suresh H; Venkatraman A; George B; Mathews V; Balasubramanian P
    Ann Hematol; 2020 May; 99(5):983-989. PubMed ID: 32277273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera.
    Schnittger S; Bacher U; Haferlach C; Geer T; Müller P; Mittermüller J; Petrides P; Schlag R; Sandner R; Selbach J; Slawik HR; Tessen HW; Wehmeyer J; Kern W; Haferlach T
    Haematologica; 2009 Mar; 94(3):414-8. PubMed ID: 19252176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders.
    Pietra D; Li S; Brisci A; Passamonti F; Rumi E; Theocharides A; Ferrari M; Gisslinger H; Kralovics R; Cremonesi L; Skoda R; Cazzola M
    Blood; 2008 Feb; 111(3):1686-9. PubMed ID: 17984312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JAK2 V617F/C618R mutation in a patient with polycythemia vera: a case study and review of the literature.
    Yoo JH; Park TS; Maeng HY; Sun YK; Kim YA; Kie JH; Cho EH; Song J; Lee KA; Suh B; Choi JR
    Cancer Genet Cytogenet; 2009 Feb; 189(1):43-7. PubMed ID: 19167611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The analysis of JAK2 and MPL mutations and JAK2 single nucleotide polymorphisms in MPN patients by MassARRAY assay.
    Zhang SJ; Qiu HX; Li JY; Shi JY; Xu W
    Int J Lab Hematol; 2010 Aug; 32(4):381-6. PubMed ID: 20331763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations.
    Passamonti F; Elena C; Schnittger S; Skoda RC; Green AR; Girodon F; Kiladjian JJ; McMullin MF; Ruggeri M; Besses C; Vannucchi AM; Lippert E; Gisslinger H; Rumi E; Lehmann T; Ortmann CA; Pietra D; Pascutto C; Haferlach T; Cazzola M
    Blood; 2011 Mar; 117(10):2813-6. PubMed ID: 21224469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels.
    Percy MJ; Scott LM; Erber WN; Harrison CN; Reilly JT; Jones FG; Green AR; McMullin MF
    Haematologica; 2007 Dec; 92(12):1607-14. PubMed ID: 18055983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid identification of heterozygous or homozygous JAK2(V617F) mutations in myeloproliferative neoplasms using melting curve analysis.
    Ho CL; Wu YY; Hung HM; Chang PY; Kao WY; Chen YC; Chao TY
    J Formos Med Assoc; 2012 Jan; 111(1):34-40. PubMed ID: 22333011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.